PTC THERAPEUTICS, INC. - Common Stock (PTCT)

CUSIP: 69366J200

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
80,855,533
Total 13F shares
82,678,571
Share change
+2,730,204
Total reported value
$5,073,764,701
Put/Call ratio
26%
Price per share
$61.37
Number of holders
290
Value change
+$181,615,186
Number of buys
151
Number of sells
143

Quarterly Holders Quick Answers

What is CUSIP 69366J200?
CUSIP 69366J200 identifies PTCT - PTC THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2025

As of 30 Sep 2025, PTC THERAPEUTICS, INC. - Common Stock (PTCT) was held by 290 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 82,678,571 shares. The largest 10 holders included VANGUARD GROUP INC, RTW INVESTMENTS, LP, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, ARMISTICE CAPITAL, LLC, TORONTO DOMINION BANK, STATE STREET CORP, D. E. Shaw & Co., Inc., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 290 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.